Molecular Targeting Probes - Radioactive & Nonradioactive -> Radiopharmacy 464

464 - Validation of multidose vial preparation fill line within F-18 Fludeoxyglucose manufacturing. (ID 338)

Session Name
Radiopharmacy
Speakers
Authors
Presentation Topic
Molecular Targeting Probes - Radioactive & Nonradioactive -> Radiopharmacy
Presentation Number
464

Previous Eposter
462 - First-in-Human study of [18F]SynVesT-2, a novel SV2A radioligand with fast kinetics and high specific binding signals (ID 867)

Next Eposters
465 - Optimization of [68Ga] Production via Cyclotron Irradiation 1.0 M Zn(NO3)2 solution for the Synthesis of [Ga-68] PSMA-11 HBED. (ID 344)
466 - Validating Cyclotron-Produced 68Ga as an Alternative Source for Compounding Radiopharmaceutical Kits (ID 337)
468 - Production of [89Zr]Oxinate4 and cell labeling for human use (ID 343)
469 - Improved synthesis of [18F]fluoro-d2-methyl tosylate suitable for automated pharmaceutical labeling (ID 342)
470 - Radiosynthesis of [18F]-flumazenil and its clinical utilization. (ID 341)
471 - Synthesis and preclinical evaluation of a molecular probe for imaging lung cancer with L858R/T790M mutation of epidermal growth factor receptor (EGFR) (ID 340)
472 - Histopathologic correlation with 68Ga PSMA PET/CT in Non Prostate Tumors. (ID 522)
473 - Clinical Application of SPECT-CT Imaging with 99mTc/PSMA T4 in patients with Recurrent Prostate Cancer (ID 523)
474 - A Pilot Study on 68Ga-PSMA-11 PET/CT in Assessing Metastatic Clear Cell Renal Cell Carcinoma (ID 521)
475 - 68Ga-PSMA PET/MRI for the Diagnoses of Primary and Biochemical Recurrent Prostate Cancer: A System Review and Meta-Analysis (ID 520)